{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:56:09Z","timestamp":1791996969911,"version":"4.4.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00210-025-04142-7","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T07:22:36Z","timestamp":1744615356000},"page":"12847-12867","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting ferroptosis: a novel pathway in oral, oropharyngeal, hypopharyngeal, and laryngeal cancers"],"prefix":"10.1007","volume":"398","author":[{"given":"Anis","family":"Elhami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"Ghasemzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahand","family":"Emrahoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Ghasemzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Mivehchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Beykoylu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshad","family":"Ashrafpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saminalsadat","family":"Ayoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin Khazeei","family":"Tabari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"issue":"1","key":"4142_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/biom15010151","volume":"15","author":"HOA Alharbi","year":"2025","unstructured":"Alharbi HOA, Alshebremi M, Babiker AY, Rahmani AH (2025) The role of quercetin, a flavonoid in the management of pathogenesis through regulation of oxidative stress, inflammation, and biological activities. Biomolecules 15(1):151","journal-title":"Biomolecules"},{"issue":"3","key":"4142_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"11\u201312","key":"4142_CR3","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","volume":"73","author":"JY Cao","year":"2016","unstructured":"Cao JY, Dixon SJ (2016) Mechanisms of ferroptosis. Cell Mol Life Sci 73(11\u201312):2195\u20132209","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"4142_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.canlet.2014.08.003","volume":"354","author":"H Chen","year":"2014","unstructured":"Chen H, Gao Y, Wu J, Chen Y, Chen B, Hu J, Zhou J (2014) Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignancies. Cancer Lett 354(1):5\u201311","journal-title":"Cancer Lett"},{"issue":"9","key":"4142_CR5","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D (2021) Ferroptosis: machinery and regulation. Autophagy 17(9):2054\u20132081","journal-title":"Autophagy"},{"key":"4142_CR6","doi-asserted-by":"publisher","first-page":"1402514","DOI":"10.3389\/fphar.2024.1402514","volume":"15","author":"R Chen","year":"2024","unstructured":"Chen R, Zhu S, Zhao R, Liu W, Jin L, Ren X, He H (2024) Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma. Front Pharmacol 15:1402514","journal-title":"Front Pharmacol"},{"issue":"5","key":"4142_CR7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","volume":"21","author":"B Chu","year":"2019","unstructured":"Chu B, Kon N, Chen D, Li T, Liu T, Jiang L, Song S, Tavana O, Gu W (2019) ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. Nat Cell Biol 21(5):579\u2013591","journal-title":"Nat Cell Biol"},{"issue":"15","key":"4142_CR8","doi-asserted-by":"publisher","first-page":"2204514","DOI":"10.1002\/advs.202204514","volume":"10","author":"C-H Chung","year":"2023","unstructured":"Chung C-H, Lin C-Y, Chen C-Y, Hsueh C-W, Chang Y-W, Wang C-C, Chu P-Y, Tai S-K, Yang M-H (2023) Ferroptosis signature shapes the immune profiles to enhance the response to immune checkpoint inhibitors in head and neck cancer. Adv Sci 10(15):2204514","journal-title":"Adv Sci"},{"issue":"9\u201310","key":"4142_CR9","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1101\/gad.314674.118","volume":"32","author":"M Conrad","year":"2018","unstructured":"Conrad M, Kagan VE, Bayir H, Pagnussat GC, Head B, Traber MG, Stockwell BR (2018) Regulation of lipid peroxidation and ferroptosis in diverse species. Genes Dev 32(9\u201310):602\u2013619","journal-title":"Genes Dev"},{"issue":"2","key":"4142_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3892\/or.2024.8764","volume":"52","author":"Q Dai","year":"2024","unstructured":"Dai Q, Wei X, Zhao J, Zhang D, Luo Y, Yang Y, Xiang Y, Liu X (2024) Inhibition of FSP1: a new strategy for the treatment of tumors (Review). Oncol Rep 52(2):105","journal-title":"Oncol Rep"},{"issue":"5","key":"4142_CR11","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR (2012a) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072","journal-title":"Cell"},{"issue":"12","key":"4142_CR12","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.3390\/molecules29122832","volume":"29","author":"HF Du","year":"2024","unstructured":"Du HF, Wu JW, Zhu YS, Hua ZH, Jin SZ, Ji JC, Wang CS, Qian GY, Jin XD, Ding HM (2024) Fucoxanthin induces ferroptosis in cancer cells via downregulation of the Nrf2\/HO\u2212 1\/GPX4 pathway. Molecules 29(12):2832","journal-title":"Molecules"},{"issue":"12","key":"4142_CR13","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3390\/pharmaceutics16121517","volume":"16","author":"R Favas","year":"2024","unstructured":"Favas R, Almeida H, Peixoto AF, Ferreira D, Silva AC (2024) Advances in encapsulating marine bioactive compounds using nanostructured lipid carriers (NLCs) and solid lipid nanoparticles (SLNs) for health applications. Pharmaceutics 16(12):1517","journal-title":"Pharmaceutics"},{"issue":"1","key":"4142_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s43556-023-00142-2","volume":"4","author":"S Feng","year":"2023","unstructured":"Feng S, Tang D, Wang Y, Li X, Bao H, Tang C, Dong X, Li X, Yang Q, Yan Y, Yin Z, Shang T, Zheng K, Huang X, Wei Z, Wang K, Qi S (2023) The mechanism of ferroptosis and its related diseases. Mol Biomed 4(1):33","journal-title":"Mol Biomed"},{"key":"4142_CR15","doi-asserted-by":"publisher","first-page":"101670","DOI":"10.1016\/j.redox.2020.101670","volume":"36","author":"DC Fuhrmann","year":"2020","unstructured":"Fuhrmann DC, Mondorf A, Beifu\u00df J, Jung M, Br\u00fcne B (2020) Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis. Redox Biol 36:101670","journal-title":"Redox Biol"},{"issue":"2","key":"4142_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","volume":"25","author":"B Galy","year":"2024","unstructured":"Galy B, Conrad M, Muckenthaler M (2024) Mechanisms controlling cellular and systemic iron homeostasis. Nat Rev Mol Cell Biol 25(2):133\u2013155","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"4142_CR17","first-page":"802","volume":"17","author":"S Gao","year":"2017","unstructured":"Gao S, Li X, Zang J, Xu W, Zhang Y (2017) Preclinical and clinical studies of chidamide (CS055\/HBI-8000), an orally available subtype-selective HDAC inhibitor for cancer therapy. Anticancer Agents Med Chem (Formerly Curr Med Chem Anticancer Agents ) 17(6):802\u2013812","journal-title":"Anticancer Agents Med Chem (Formerly Curr Med Chem Anticancer Agents )"},{"key":"4142_CR18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3897\/pharmacia.69.e87716","volume":"69","author":"T Georgiev","year":"2022","unstructured":"Georgiev T, Hadzhibozheva P, Karamalakova Y, Georgieva E, Perinkadakatt F, Ilinov Z, Petkov K, Ananiev J (2022) Therapeutic approach of glutathione\/glutathione peroxidase-4 axis modulation in the light of ferroptosis. Pharmacia 69:839\u2013846","journal-title":"Pharmacia"},{"issue":"8","key":"4142_CR19","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/life11080835","volume":"11","author":"Q Guo","year":"2021","unstructured":"Guo Q, Zhang X, Shen T, Wang X (2021) Identification of autophagy- and ferroptosis-related lncRNAs functioned through immune-related pathways in head and neck squamous carcinoma. Life 11(8):835","journal-title":"Life"},{"issue":"8","key":"4142_CR20","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1007\/s00405-021-06789-3","volume":"278","author":"F Han","year":"2021","unstructured":"Han F, Li W, Chen T, Yao Y, Li J, Wang D, Wang Z (2021) Ferroptosis-related genes for predicting prognosis of patients with laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 278(8):2919\u20132925","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"6","key":"4142_CR21","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T (2019) Targeting ferroptosis to iron out cancer. Cancer Cell 35(6):830\u2013849","journal-title":"Cancer Cell"},{"key":"4142_CR22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","volume":"133","author":"T Hirschhorn","year":"2019","unstructured":"Hirschhorn T, Stockwell BR (2019) The development of the concept of ferroptosis. Free Radic Biol Med 133:130\u2013143","journal-title":"Free Radic Biol Med"},{"key":"4142_CR23","doi-asserted-by":"publisher","first-page":"102187","DOI":"10.1016\/j.tice.2023.102187","volume":"84","author":"L Huang","year":"2023","unstructured":"Huang L, Chen G, He J, Wang P (2023) ZC3H13 reduced DUOX1-mediated ferroptosis in laryngeal squamous cell carcinoma cells through m6A-dependent modification. Tissue Cell 84:102187","journal-title":"Tissue Cell"},{"key":"4142_CR24","doi-asserted-by":"publisher","first-page":"116670","DOI":"10.1016\/j.ejmech.2024.116670","volume":"276","author":"W Huang","year":"2024","unstructured":"Huang W, Guo Y, Qian Y, Liu X, Li G, Wang J, Yang X, Wu M, Fan Y, Luo H, Chen Y, Zhang L, Yang N, Liu Z, Liu Y (2024) Ferroptosis-inducing compounds synergize with docetaxel to overcome chemoresistance in docetaxel-resistant non-small cell lung cancer cells. Eur J Med Chem 276:116670","journal-title":"Eur J Med Chem"},{"issue":"11","key":"4142_CR25","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1007\/s00405-022-07433-4","volume":"279","author":"Z Ji","year":"2022","unstructured":"Ji Z, Fang Z, Dong X, Wang J, Wan X, Yan A (2022) Potential ferroptosis-related diagnostic and prognostic biomarkers in laryngeal cancer. Eur Arch Otorhinolaryngol 279(11):5277\u20135288","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"4142_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"19","key":"4142_CR27","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.3390\/ijms20194968","volume":"20","author":"N Kajarabille","year":"2019","unstructured":"Kajarabille N, Latunde-Dada GO (2019) Programmed cell-death by ferroptosis: antioxidants as mitigators. Int J Mol Sci 20(19):4968","journal-title":"Int J Mol Sci"},{"key":"4142_CR28","doi-asserted-by":"publisher","first-page":"116363","DOI":"10.1016\/j.biopha.2024.116363","volume":"173","author":"F Khan","year":"2024","unstructured":"Khan F, Pandey P, Verma M, Ramniwas S, Lee D, Moon S, Park MN, Upadhyay TK, Kim B (2024) Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy. Biomed Pharmacother 173:116363","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"4142_CR29","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s12276-023-01077-y","volume":"55","author":"JW Kim","year":"2023","unstructured":"Kim JW, Lee J-Y, Oh M, Lee E-W (2023) An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis. Exp Mol Med 55(8):1620\u20131631","journal-title":"Exp Mol Med"},{"issue":"8","key":"4142_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B (2021a) Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12(8):599\u2013620","journal-title":"Protein Cell"},{"issue":"9","key":"4142_CR31","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s13238-021-00823-0","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B (2021b) Cytochrome P450 reductase (POR) as a ferroptosis fuel. Protein Cell 12(9):675\u2013679","journal-title":"Protein Cell"},{"key":"4142_CR32","doi-asserted-by":"publisher","first-page":"103887","DOI":"10.1016\/j.critrevonc.2022.103887","volume":"181","author":"J Lee","year":"2023","unstructured":"Lee J, Roh JL (2023) Ferroptosis induction via targeting metabolic alterations in head and neck cancer. Crit Rev Oncol Hematol 181:103887","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"4142_CR33","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41419-023-05978-8","volume":"14","author":"S Lee","year":"2023","unstructured":"Lee S, Hwang N, Seok BG, Lee S, Lee SJ, Chung SW (2023) Autophagy mediates an amplification loop during ferroptosis. Cell Death Dis 14(7):464","journal-title":"Cell Death Dis"},{"key":"4142_CR34","doi-asserted-by":"publisher","first-page":"e69621","DOI":"10.7554\/eLife.69621","volume":"10","author":"MJ Lehrke","year":"2021","unstructured":"Lehrke MJ, Shapiro MJ, Rajcula MJ, Kennedy MM, McCue SA, Medina KL, Shapiro VS (2021) The mitochondrial iron transporter ABCB7 is required for B cell development, proliferation, and class switch recombination in mice. Elife 10:e69621","journal-title":"Elife"},{"issue":"2","key":"4142_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin H-L, Huang Z-J, Lin Z-T, Mao N, Sun B, Wang G (2020) Ferroptosis: past, present and future. Cell Death Dis 11(2):88","journal-title":"Cell Death Dis"},{"key":"4142_CR36","doi-asserted-by":"publisher","first-page":"113279","DOI":"10.1016\/j.biopha.2022.113279","volume":"153","author":"D Li","year":"2022","unstructured":"Li D, Pi W, Sun Z, Liu X, Jiang J (2022a) Ferroptosis and its role in cardiomyopathy. Biomed Pharmacother 153:113279","journal-title":"Biomed Pharmacother"},{"key":"4142_CR37","doi-asserted-by":"publisher","first-page":"910292","DOI":"10.3389\/fphar.2022.910292","volume":"13","author":"FJ Li","year":"2022","unstructured":"Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, Gao LC (2022b) System X(c) (-)\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol 13:910292","journal-title":"Front Pharmacol"},{"issue":"11","key":"4142_CR38","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41419-023-06280-3","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Ma Z, Li W, Xu X, Shen P, Zhang SE, Cheng B, Xia J (2023) PDPN(+) CAFs facilitate the motility of OSCC cells by inhibiting ferroptosis via transferring exosomal lncRNA FTX. Cell Death Dis 14(11):759","journal-title":"Cell Death Dis"},{"key":"4142_CR39","doi-asserted-by":"publisher","first-page":"116825","DOI":"10.1016\/j.taap.2024.116825","volume":"484","author":"R Li","year":"2024","unstructured":"Li R, Hu Z, Qiao Q, Zhou D, Sun M (2024) Anti-NOTCH1 therapy with OMP-52 M51 inhibits salivary adenoid cystic carcinoma by depressing epithelial-mesenchymal transition (EMT) process and inducing ferroptosis. Toxicol Appl Pharmacol 484:116825","journal-title":"Toxicol Appl Pharmacol"},{"key":"4142_CR40","doi-asserted-by":"publisher","first-page":"105807","DOI":"10.1016\/j.archoralbio.2023.105807","volume":"156","author":"B Liang","year":"2023","unstructured":"Liang B, Wu Y (2023) Hsa-miR-26a-5p improves OSCC sensitivity to ferroptosis by inhibiting SLC7A11. Arch Oral Biol 156:105807","journal-title":"Arch Oral Biol"},{"issue":"12","key":"4142_CR41","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang D, Minikes AM, Jiang X (2022) Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell 82(12):2215\u20132227","journal-title":"Mol Cell"},{"issue":"1","key":"4142_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13062-024-00499-6","volume":"19","author":"Y Liang","year":"2024","unstructured":"Liang Y, Zhong H, Zhao Y, Tang X, Pan C, Sun J, Sun J (2024) Epigenetic mechanism of RBM15 in affecting cisplatin resistance in laryngeal carcinoma cells by regulating ferroptosis. Biol Direct 19(1):57","journal-title":"Biol Direct"},{"issue":"8","key":"4142_CR43","doi-asserted-by":"publisher","first-page":"2100396","DOI":"10.1002\/adbi.202100396","volume":"5","author":"Z Lin","year":"2021","unstructured":"Lin Z, Liu J, Kang R, Yang M, Tang D (2021) Lipid metabolism in ferroptosis. Adv Biol 5(8):2100396","journal-title":"Adv Biol"},{"issue":"5","key":"4142_CR44","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41418-022-00943-y","volume":"29","author":"Y Liu","year":"2022","unstructured":"Liu Y, Gu W (2022) p53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death Differ 29(5):895\u2013910","journal-title":"Cell Death Differ"},{"issue":"21","key":"4142_CR45","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.3390\/molecules25215166","volume":"25","author":"Y Liu","year":"2020","unstructured":"Liu Y, You Y, Lu J, Chen X, Yang Z (2020) Recent advances in synthesis, bioactivity, and pharmacokinetics of pterostilbene, an important analog of resveratrol. Molecules 25(21):5166","journal-title":"Molecules"},{"key":"4142_CR46","doi-asserted-by":"publisher","first-page":"106398","DOI":"10.1016\/j.biocel.2023.106398","volume":"158","author":"X Liu","year":"2023","unstructured":"Liu X, Li W, Xu L, Chen X, Zhao R, Guo Y, Ge J, Yang Z, Li L, Zhang J, Cao J, Shao Y, Guo X, Tian L, Liu M (2023) Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo. Int J Biochem Cell Biol 158:106398","journal-title":"Int J Biochem Cell Biol"},{"issue":"11","key":"4142_CR47","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/cbin.12211","volume":"48","author":"Y Liu","year":"2024","unstructured":"Liu Y, Bai Q, Pang N, Xue J (2024) TCF12 induces ferroptosis by suppressing OTUB1-mediated SLC7A11 deubiquitination to promote cisplatin sensitivity in oral squamous cell carcinoma. Cell Biol Int 48(11):1649\u20131663","journal-title":"Cell Biol Int"},{"key":"4142_CR48","doi-asserted-by":"publisher","first-page":"1085581","DOI":"10.3389\/fonc.2023.1085581","volume":"13","author":"Z Lu","year":"2023","unstructured":"Lu Z, Xiao B, Chen W, Tang T, Zhuo Q, Chen X (2023) The potential of ferroptosis combined with radiotherapy in cancer treatment. Front Oncol 13:1085581","journal-title":"Front Oncol"},{"issue":"10","key":"4142_CR49","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2174\/0115680096294098240123104657","volume":"24","author":"Q Luo","year":"2024","unstructured":"Luo Q, Hu S, Tang Y, Yang D, Chen Q (2024) PPT1 promotes growth and inhibits ferroptosis of oral squamous cell carcinoma cells. Curr Cancer Drug Targets 24(10):1047\u20131060","journal-title":"Curr Cancer Drug Targets"},{"key":"4142_CR50","first-page":"1079","volume":"16","author":"Y Ma","year":"2023","unstructured":"Ma Y, Gao J, Guo H (2023) Circ_0000140 alters miR-527\/SLC7A11-mediated ferroptosis to influence oral squamous cell carcinoma cell resistance to DDP. Pharmgenomics Pers Med 16:1079\u20131089","journal-title":"Pharmgenomics Pers Med"},{"key":"4142_CR51","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.freeradbiomed.2023.09.001","volume":"208","author":"T Manivarma","year":"2023","unstructured":"Manivarma T, Kapralov AA, Samovich SN, Tyurina YY, Tyurin VA, VanDemark AP, Nowak W, Bay\u0131r H, Bahar I, Kagan VE, Mikulska-Ruminska K (2023) Membrane regulation of 15LOX-1\/PEBP1 complex prompts the generation of ferroptotic signals, oxygenated PEs. Free Radical Biol Med 208:458\u2013467","journal-title":"Free Radical Biol Med"},{"issue":"1","key":"4142_CR52","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1186\/s12903-024-04395-3","volume":"24","author":"C Mao","year":"2024","unstructured":"Mao C, Gong L, Kang W (2024) Effect and mechanism of resveratrol on ferroptosis mediated by p53\/SLC7A11 in oral squamous cell carcinoma. BMC Oral Health 24(1):773","journal-title":"BMC Oral Health"},{"issue":"5","key":"4142_CR53","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/cells12050804","volume":"12","author":"MS Mortensen","year":"2023","unstructured":"Mortensen MS, Ruiz J, Watts JL (2023) Polyunsaturated fatty acids drive lipid peroxidation during ferroptosis. Cells 12(5):804","journal-title":"Cells"},{"key":"4142_CR54","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3389\/fnins.2019.01195","volume":"13","author":"BB Muhoberac","year":"2019","unstructured":"Muhoberac BB, Vidal R (2019) Iron, ferritin, hereditary ferritinopathy, and neurodegeneration. Front Neurosci 13:1195","journal-title":"Front Neurosci"},{"key":"4142_CR55","doi-asserted-by":"publisher","first-page":"879317","DOI":"10.3389\/fphar.2022.879317","volume":"13","author":"Z Nie","year":"2022","unstructured":"Nie Z, Chen M, Gao Y, Huang D, Cao H, Peng Y, Guo N, Wang F, Zhang S (2022) Ferroptosis and tumor drug resistance: current status and major challenges. Front Pharmacol 13:879317","journal-title":"Front Pharmacol"},{"issue":"4","key":"4142_CR56","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/md20040222","volume":"20","author":"A Pajot","year":"2022","unstructured":"Pajot A, Hao Huynh G, Picot L, Marchal L, Nicolau E (2022) Fucoxanthin from algae to human, an extraordinary bioresource: insights and advances in up and downstream processes. Marine Drugs 20(4):222","journal-title":"Marine Drugs"},{"issue":"4","key":"4142_CR57","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/pharmaceutics12040365","volume":"12","author":"H Park","year":"2020","unstructured":"Park H, Ha E-S, Kim M-S (2020) Current status of supersaturable self-emulsifying drug delivery systems. Pharmaceutics 12(4):365","journal-title":"Pharmaceutics"},{"issue":"16","key":"4142_CR58","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.3390\/molecules29163964","volume":"29","author":"J Park","year":"2024","unstructured":"Park J, Hao Q, Jeong DI, Kim HJ, Kim S, Lee SY, Chu S, Hyun U, Cho HJ (2024) Cascade hydroxyl radical-generating and ferroptosis-inducing nanofiber system for the therapy of oral squamous cell carcinoma. Molecules 29(16):3964","journal-title":"Molecules"},{"issue":"24","key":"4142_CR59","doi-asserted-by":"publisher","first-page":"17279","DOI":"10.3390\/ijms242417279","volume":"24","author":"GT Patan\u00e8","year":"2023","unstructured":"Patan\u00e8 GT, Putaggio S, Tellone E, Barreca D, Ficarra S, Maffei C, Calderaro A, Lagan\u00e0 G (2023) Ferroptosis: emerging role in diseases and potential implication of bioactive compounds. Int J Mol Sci 24(24):17279","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4142_CR60","doi-asserted-by":"publisher","first-page":"15968","DOI":"10.1038\/s41598-024-65079-0","volume":"14","author":"Y Rao","year":"2024","unstructured":"Rao Y, Li J, Shi L, Chen X, Hu Y, Mao Y, Zhang X, Liu X (2024) Silencing CK19 regulates ferroptosis by affecting the expression of GPX4 and ACSL4 in oral squamous cell carcinoma in vivo and in vitro. Sci Rep 14(1):15968","journal-title":"Sci Rep"},{"issue":"2","key":"4142_CR61","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/antiox11020278","volume":"11","author":"KM Rodr\u00edguez-Graciani","year":"2022","unstructured":"Rodr\u00edguez-Graciani KM, Chapa-Dubocq XR, Ayala-Arroyo EJ, Chaves-Negr\u00f3n I, Jang S, Chorna N, Maskrey TS, Wipf P, Javadov S (2022) Effects of ferroptosis on the metabolome in cardiac cells: the role of glutaminolysis. Antioxidants 11(2):278","journal-title":"Antioxidants"},{"issue":"3","key":"4142_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/biomedicines6030091","volume":"6","author":"B Salehi","year":"2018","unstructured":"Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, Fokou PVT, Martins N, Sharifi-Rad J (2018) Resveratrol: a double-edged sword in health benefits. Biomedicines 6(3):91","journal-title":"Biomedicines"},{"issue":"6","key":"4142_CR63","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1111\/odi.14827","volume":"30","author":"K Sato","year":"2024","unstructured":"Sato K, Yang M, Nakamura K, Tanaka H, Hori M, Nishio M, Suzuki A, Hibi H, Toyokuni S (2024) Ferroptosis induced by plasma-activated Ringer\u2019s lactate solution prevents oral cancer progression. Oral Dis 30(6):3912\u20133924","journal-title":"Oral Dis"},{"key":"4142_CR64","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt TM, Proneth B, Conrad M (2019) Role of GPX4 in ferroptosis and its pharmacological implication. Free Radical Biol Med 133:144\u2013152","journal-title":"Free Radical Biol Med"},{"key":"4142_CR65","doi-asserted-by":"publisher","first-page":"1006535","DOI":"10.3389\/fbioe.2022.1006535","volume":"10","author":"M Shi","year":"2022","unstructured":"Shi M, Du J, Shi J, Huang Y, Zhao Y, Ma L (2022) Ferroptosis-related gene ATG5 is a novel prognostic biomarker in nasopharyngeal carcinoma and head and neck squamous cell carcinoma. Front Bioeng Biotechnol 10:1006535","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"4142_CR66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gasc\u00f3n S, Hatzios SK, Kagan VE, Noel K (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171(2):273\u201385","journal-title":"Cell"},{"issue":"4","key":"4142_CR67","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/nano10040656","volume":"10","author":"S Su","year":"2020","unstructured":"Su S, Kang PM (2020) Systemic review of biodegradable nanomaterials in nanomedicine. Nanomaterials (Basel) 10(4):656","journal-title":"Nanomaterials (Basel)"},{"key":"4142_CR68","doi-asserted-by":"publisher","first-page":"153778","DOI":"10.1016\/j.prp.2022.153778","volume":"231","author":"K Sun","year":"2022","unstructured":"Sun K, Ren W, Li S, Zheng J, Huang Y, Zhi K, Gao L (2022) MiR-34c-3p upregulates erastin-induced ferroptosis to inhibit proliferation in oral squamous cell carcinomas by targeting SLC7A11. Pathol Res Pract 231:153778","journal-title":"Pathol Res Pract"},{"key":"4142_CR69","doi-asserted-by":"publisher","first-page":"144360","DOI":"10.1016\/j.cej.2023.144360","volume":"470","author":"K Sun","year":"2023","unstructured":"Sun K, Yu J, Hu J, Yang W, Chu X, Chen L, Deng X, Sun B, Wang Z (2023a) Photothermal enhanced polyphenol-based nanofibers ameliorate catalytic efficiency of ferroptosis for synergistic tumor therapy. Chem Eng J 470:144360","journal-title":"Chem Eng J"},{"issue":"1","key":"4142_CR70","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J, Wang F, Min J (2023b) Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther 8(1):372","journal-title":"Signal Transduct Target Ther"},{"key":"4142_CR71","doi-asserted-by":"publisher","first-page":"1432520","DOI":"10.3389\/fphar.2024.1432520","volume":"15","author":"K Sun","year":"2024","unstructured":"Sun K, Gao L, Li S, Zheng J, Zhu Z, Zhi K, Ren W (2024) Circ-CDK8 regulates SLC7A11-mediated ferroptosis by inhibiting miR-615-5p to promote progression in oral squamous cell carcinomas. Front Pharmacol 15:1432520","journal-title":"Front Pharmacol"},{"issue":"3","key":"4142_CR72","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"4142_CR73","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.3390\/molecules26092506","volume":"26","author":"WH Talib","year":"2021","unstructured":"Talib WH, Alsayed AR, Abuawad A, Daoud S, Mahmod AI (2021) Melatonin in cancer treatment: current knowledge and future opportunities. Molecules 26(9):2506","journal-title":"Molecules"},{"issue":"11","key":"4142_CR74","doi-asserted-by":"publisher","first-page":"e31676","DOI":"10.1016\/j.heliyon.2024.e31676","volume":"10","author":"Z Tang","year":"2024","unstructured":"Tang Z, Chen Y, Huang Y, Zhao J, Jia B (2024) Novel ferroptosis signature for improving prediction of prognosis and indicating gene targets from single-cell level in oral squamous cell carcinoma. Heliyon 10(11):e31676","journal-title":"Heliyon"},{"issue":"2","key":"4142_CR75","doi-asserted-by":"publisher","first-page":"73","DOI":"10.25259\/IJMIO_2_2020","volume":"5","author":"R Thavarajah","year":"2020","unstructured":"Thavarajah R (2020) mRNA expression of ferroptosis-related proteins in squamous cell carcinoma of tongue. Int J Mol Immuno Oncol 5(2):73\u201381","journal-title":"Int J Mol Immuno Oncol"},{"issue":"8","key":"4142_CR76","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3390\/nu13082751","volume":"13","author":"P Vermonden","year":"2021","unstructured":"Vermonden P, Vancoppenolle M, Dierge E, Mignolet E, Cuvelier G, Knoops B, Page M, Debier C, Feron O, Larondelle Y (2021) Punicic acid triggers ferroptotic cell death in carcinoma cells. Nutrients 13(8):2751","journal-title":"Nutrients"},{"key":"4142_CR77","doi-asserted-by":"publisher","first-page":"115363","DOI":"10.1016\/j.taap.2020.115363","volume":"410","author":"X Wang","year":"2021","unstructured":"Wang X, Liu K, Gong H, Li D, Chu W, Zhao D, Wang X, Xu D (2021) Death by histone deacetylase inhibitor quisinostat in tongue squamous cell carcinoma via apoptosis, pyroptosis, and ferroptosis. Toxicol Appl Pharmacol 410:115363","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"4142_CR78","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s11658-023-00449-6","volume":"28","author":"L Wang","year":"2023","unstructured":"Wang L, Wang C, Li X, Tao Z, Zhu W, Su Y, Choi WS (2023a) Melatonin and erastin emerge synergistic anti-tumor effects on oral squamous cell carcinoma by inducing apoptosis, ferroptosis, and inhibiting autophagy through promoting ROS. Cell Mol Biol Lett 28(1):36","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"4142_CR79","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12964-023-01170-9","volume":"21","author":"X Wang","year":"2023","unstructured":"Wang X, Tan X, Zhang J, Wu J, Shi H (2023b) The emerging roles of MAPK-AMPK in ferroptosis regulatory network. Cell Commun Signal 21(1):200","journal-title":"Cell Commun Signal"},{"issue":"11","key":"4142_CR80","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1038\/s41416-024-02670-2","volume":"130","author":"Z Wang","year":"2024","unstructured":"Wang Z, Tang S, Cai L, Wang Q, Pan D, Dong Y, Zhou H, Li J, Ji N, Zeng X, Zhou Y, Shen YQ, Chen Q (2024a) DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma. Br J Cancer 130(11):1744\u20131757","journal-title":"Br J Cancer"},{"issue":"1","key":"4142_CR81","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13046-024-03039-2","volume":"43","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zong H, Liu W, Lin W, Sun A, Ding Z, Chen X, Wan X, Liu Y, Hu Z, Zhang H, Li H, Liu Y, Li D, Zhang S, Zha X (2024b) Augmented ERO1\u03b1 upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11. J Exp Clin Cancer Res 43(1):112","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"4142_CR82","doi-asserted-by":"publisher","first-page":"e3669","DOI":"10.1002\/jgm.3669","volume":"26","author":"Z Wen","year":"2024","unstructured":"Wen Z, Zhang Y, Gao B, Chen X (2024) Baicalin induces ferroptosis in oral squamous cell carcinoma by suppressing the activity of FTH1. J Gene Med 26(2):e3669","journal-title":"J Gene Med"},{"issue":"7","key":"4142_CR83","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/cam4.1110","volume":"6","author":"Y Wu","year":"2017","unstructured":"Wu Y, Sun X, Song B, Qiu X, Zhao J (2017) MiR-375\/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion. Cancer Med 6(7):1686\u20131697","journal-title":"Cancer Med"},{"issue":"1","key":"4142_CR84","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41065-022-00225-0","volume":"159","author":"F Wu","year":"2022","unstructured":"Wu F, Xiong G, Chen Z, Lei C, Liu Q, Bai Y (2022) SLC3A2 inhibits ferroptosis in laryngeal carcinoma via mTOR pathway. Hereditas 159(1):6","journal-title":"Hereditas"},{"issue":"2","key":"4142_CR85","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/10715762.2024.2320396","volume":"58","author":"K Wu","year":"2024","unstructured":"Wu K, Liu L, Wu Z, Huang Q, Zhou L, Xie R, Wang M (2024) Ascorbic acid induces ferroptosis via STAT3\/GPX4 signaling in oropharyngeal cancer. Free Radic Res 58(2):117\u2013129","journal-title":"Free Radic Res"},{"issue":"9","key":"4142_CR86","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1002\/hed.27442","volume":"45","author":"Y Xia","year":"2023","unstructured":"Xia Y, Hei N, Peng S, Cui Z (2023) The role and mechanism of circ-BNC2 on the malignant progression of oral squamous cell carcinoma. Head Neck 45(9):2424\u20132437","journal-title":"Head Neck"},{"issue":"1","key":"4142_CR87","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12903-023-03046-3","volume":"23","author":"J Xie","year":"2023","unstructured":"Xie J, Lan T, Zheng DL, Ding LC, Lu YG (2023a) CDH4 inhibits ferroptosis in oral squamous cell carcinoma cells. BMC Oral Health 23(1):329","journal-title":"BMC Oral Health"},{"issue":"10","key":"4142_CR88","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","volume":"19","author":"Y Xie","year":"2023","unstructured":"Xie Y, Kang R, Klionsky DJ, Tang D (2023b) GPX4 in cell death, autophagy, and disease. Autophagy 19(10):2621\u20132638","journal-title":"Autophagy"},{"issue":"5","key":"4142_CR89","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1158\/2326-6066.CIR-23-0595","volume":"12","author":"L Xu","year":"2024","unstructured":"Xu L, Li W, Liu D, Cao J, Ge J, Liu X, Wang Y, Teng Y, Liu P, Guo X, He C, Liu M, Tian L (2024a) ANXA3-rich exosomes derived from tumor-associated macrophages regulate ferroptosis and lymphatic metastasis of laryngeal squamous cell carcinoma. Cancer Immunol Res 12(5):614\u2013630","journal-title":"Cancer Immunol Res"},{"key":"4142_CR90","doi-asserted-by":"publisher","unstructured":"Xu M, Hu X, Xiao Z, Zhang S, Lu Z (2024b) Silencing KPNA2 promotes ferroptosis in laryngeal cancer by activating the FoxO signaling pathway. Biochem Genet 1\u201317. https:\/\/doi.org\/10.1007\/s10528-023-10655-8","DOI":"10.1007\/s10528-023-10655-8"},{"key":"4142_CR91","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jconrel.2023.12.056","volume":"366","author":"Y Xu","year":"2024","unstructured":"Xu Y, Yang L, Wang C, Sun W, Zheng Y, Ou B, Wu L, Shi L, Lin X, Chen W (2024c) Ferroptosis boosted oral cancer photodynamic therapy by carrier-free sorafenib-Ce6 self-assembly nanoparticles. J Control Release 366:798\u2013811","journal-title":"J Control Release"},{"key":"4142_CR92","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.biopha.2018.01.110","volume":"99","author":"S Yang","year":"2018","unstructured":"Yang S, Nan P, Li C, Lin F, Li H, Wang T, Zhou C, Zhang X, Meng X, Qian H, Wang H, Dong M (2018) Inhibitory effect of chidamide on the growth of human adenoid cystic carcinoma cells. Biomed Pharmacother 99:608\u2013614","journal-title":"Biomed Pharmacother"},{"key":"4142_CR93","doi-asserted-by":"publisher","first-page":"672724","DOI":"10.3389\/fonc.2021.672724","volume":"11","author":"J Yang","year":"2021","unstructured":"Yang J, Cao XH, Luan KF, Huang YD (2021) Circular RNA FNDC3B protects oral squamous cell carcinoma cells from ferroptosis and contributes to the malignant progression by regulating miR-520d-5p\/SLC7A11 axis. Front Oncol 11:672724","journal-title":"Front Oncol"},{"key":"4142_CR94","doi-asserted-by":"publisher","first-page":"101360","DOI":"10.1016\/j.tranon.2022.101360","volume":"18","author":"Y Yang","year":"2022","unstructured":"Yang Y, Tang H, Zheng J, Yang K (2022) The PER1\/HIF-1alpha negative feedback loop promotes ferroptosis and inhibits tumor progression in oral squamous cell carcinoma. Transl Oncol 18:101360","journal-title":"Transl Oncol"},{"key":"4142_CR95","doi-asserted-by":"publisher","first-page":"9783","DOI":"10.2147\/CMAR.S217944","volume":"11","author":"J Ye","year":"2019","unstructured":"Ye J, Jiang X, Dong Z, Hu S, Xiao M (2019) Low-concentration PTX and RSL3 inhibits tumor cell growth synergistically by inducing ferroptosis in mutant p53 hypopharyngeal squamous carcinoma. Cancer Manag Res 11:9783\u20139792","journal-title":"Cancer Manag Res"},{"issue":"7","key":"4142_CR96","doi-asserted-by":"publisher","first-page":"e24514","DOI":"10.1002\/jcla.24514","volume":"36","author":"J Ye","year":"2022","unstructured":"Ye J, Chen X, Jiang X, Dong Z, Hu S, Xiao M (2022) RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2\/NRF2 in an m(6) A-IGF2BP2-dependent manner. J Clin Lab Anal 36(7):e24514","journal-title":"J Clin Lab Anal"},{"issue":"11","key":"4142_CR97","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3390\/pharmaceutics13111785","volume":"13","author":"N Zaffaroni","year":"2021","unstructured":"Zaffaroni N, Beretta GL (2021) Nanoparticles for ferroptosis therapy in cancer. Pharmaceutics 13(11):1785","journal-title":"Pharmaceutics"},{"key":"4142_CR98","doi-asserted-by":"publisher","first-page":"115909","DOI":"10.1016\/j.bcp.2023.115909","volume":"218","author":"D Zhang","year":"2023","unstructured":"Zhang D, Jia X, Lin D, Ma J (2023) Melatonin and ferroptosis: mechanisms and therapeutic implications. Biochem Pharmacol 218:115909","journal-title":"Biochem Pharmacol"},{"key":"4142_CR99","doi-asserted-by":"publisher","first-page":"149842","DOI":"10.1016\/j.bbrc.2024.149842","volume":"709","author":"L Zhang","year":"2024","unstructured":"Zhang L, Li Z, Ma X, Yang W, Hao Y, Zhang L, Piao S (2024) Combination treatment with ferroptosis and autophagy inducers significantly inhibit the proliferation and migration of oral squamous cell carcinoma. Biochem Biophys Res Commun 709:149842","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4142_CR100","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3892\/or.2014.3595","volume":"33","author":"B Zhao","year":"2015","unstructured":"Zhao B, He T (2015) Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax\/Bcl-2 and P21 in pancreatic cancer. Oncol Rep 33(1):304\u2013310","journal-title":"Oncol Rep"},{"issue":"11","key":"4142_CR101","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3390\/ph15111360","volume":"15","author":"X Zhao","year":"2022","unstructured":"Zhao X, Wang X, Pang Y (2022) Phytochemicals targeting ferroptosis: therapeutic opportunities and prospects for treating breast cancer. Pharmaceuticals (Basel) 15(11):1360","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"4142_CR102","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/odi.14077","volume":"29","author":"Y-Y Zhao","year":"2023","unstructured":"Zhao Y-Y, Lian J-X, Lan Z, Zou K-L, Wang W-M, Yu G-T (2023) Ferroptosis promotes anti-tumor immune response by inducing immunogenic exposure in HNSCC. Oral Dis 29(3):933\u2013941","journal-title":"Oral Dis"},{"issue":"7","key":"4142_CR103","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41419-021-03998-w","volume":"12","author":"J Zheng","year":"2021","unstructured":"Zheng J, Sato M, Mishima E, Sato H, Proneth B, Conrad M (2021) Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines. Cell Death Dis 12(7):698","journal-title":"Cell Death Dis"},{"issue":"22","key":"4142_CR104","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.3390\/cells11223653","volume":"11","author":"L Zhou","year":"2022","unstructured":"Zhou L, Han S, Guo J, Qiu T, Zhou J, Shen L (2022a) Ferroptosis\u2014a new dawn in the treatment of organ ischemia\u2013reperfusion injury. Cells 11(22):3653","journal-title":"Cells"},{"issue":"1","key":"4142_CR105","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12903-022-02503-9","volume":"22","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Wang X, Zhang Y, Wang L, Chen Z (2022b) Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis. BMC Oral Health 22(1):478","journal-title":"BMC Oral Health"},{"issue":"1","key":"4142_CR106","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, Sun Y, Zeng F, Chen X, Deng G (2024a) Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther 9(1):55","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"4142_CR107","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.7150\/thno.32867","volume":"9","author":"T Zhu","year":"2019","unstructured":"Zhu T, Shi L, Yu C, Dong Y, Qiu F, Shen L, Qian Q, Zhou G, Zhu X (2019) Ferroptosis promotes photodynamic therapy: supramolecular photosensitizer-inducer nanodrug for enhanced cancer treatment. Theranostics 9(11):3293\u20133307","journal-title":"Theranostics"},{"issue":"6","key":"4142_CR108","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/15376516.2024.2325989","volume":"34","author":"YW Zhu","year":"2024","unstructured":"Zhu YW, Liu CL, Li XM, Shang Y (2024) Quercetin induces ferroptosis by inactivating mTOR\/S6KP70 pathway in oral squamous cell carcinoma. Toxicol Mech Methods 34(6):669\u2013675","journal-title":"Toxicol Mech Methods"},{"issue":"3","key":"4142_CR109","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","volume":"16","author":"Y Zou","year":"2020","unstructured":"Zou Y, Li H, Graham ET, Deik AA, Eaton JK, Wang W, Sandoval-Gomez G, Clish CB, Doench JG, Schreiber SL (2020) Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol 16(3):302\u2013309","journal-title":"Nat Chem Biol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04142-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04142-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04142-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T05:02:40Z","timestamp":1759986160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04142-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":109,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4142"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04142-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}